These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10749118)

  • 1. Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1.
    Futamura M; Arakawa H; Matsuda K; Katagiri T; Saji S; Miki Y; Nakamura Y
    Cancer Res; 2000 Mar; 60(6):1531-5. PubMed ID: 10749118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
    Gupta A; Inaba S; Wong OK; Fang G; Liu J
    Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
    Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
    Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase.
    Milner J; Fuks F; Hughes-Davies L; Kouzarides T
    Oncogene; 2000 Sep; 19(38):4441-5. PubMed ID: 10980621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51.
    Katagiri T; Saito H; Shinohara A; Ogawa H; Kamada N; Nakamura Y; Miki Y
    Genes Chromosomes Cancer; 1998 Mar; 21(3):217-22. PubMed ID: 9523196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BUBR1 phosphorylation is regulated during mitotic checkpoint activation.
    Li W; Lan Z; Wu H; Wu S; Meadows J; Chen J; Zhu V; Dai W
    Cell Growth Differ; 1999 Nov; 10(11):769-75. PubMed ID: 10593653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p55CDC/hCDC20 is associated with BUBR1 and may be a downstream target of the spindle checkpoint kinase.
    Wu H; Lan Z; Li W; Wu S; Weinstein J; Sakamoto KM; Dai W
    Oncogene; 2000 Sep; 19(40):4557-62. PubMed ID: 11030144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.
    Shichiri M; Yoshinaga K; Hisatomi H; Sugihara K; Hirata Y
    Cancer Res; 2002 Jan; 62(1):13-7. PubMed ID: 11782350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitotic checkpoint gene BubR1 has two distinct functions in mitosis.
    Harris L; Davenport J; Neale G; Goorha R
    Exp Cell Res; 2005 Aug; 308(1):85-100. PubMed ID: 15907836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.
    Lee H
    Exp Mol Med; 2003 Oct; 35(5):448-53. PubMed ID: 14646599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation.
    Shin HJ; Baek KH; Jeon AH; Kim SJ; Jang KL; Sung YC; Kim CM; Lee CW
    Oncogene; 2003 Jun; 22(25):3853-8. PubMed ID: 12813458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle control of BRCA2.
    Vaughn JP; Cirisano FD; Huper G; Berchuck A; Futreal PA; Marks JR; Iglehart JD
    Cancer Res; 1996 Oct; 56(20):4590-4. PubMed ID: 8840967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2.
    Sharan SK; Morimatsu M; Albrecht U; Lim DS; Regel E; Dinh C; Sands A; Eichele G; Hasty P; Bradley A
    Nature; 1997 Apr; 386(6627):804-10. PubMed ID: 9126738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells.
    Wang X; Jin DY; Wong HL; Feng H; Wong YC; Tsao SW
    Oncogene; 2003 Jan; 22(1):109-16. PubMed ID: 12527913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining.
    Xia F; Taghian DG; DeFrank JS; Zeng ZC; Willers H; Iliakis G; Powell SN
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8644-9. PubMed ID: 11447276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression.
    Su LK; Wang SC; Qi Y; Luo W; Hung MC; Lin SH
    Oncogene; 1998 Nov; 17(18):2377-81. PubMed ID: 9811469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor.
    Vera J; Jaumot M; Estanyol JM; Brun S; Agell N; Bachs O
    Oncogene; 2006 Jan; 25(2):260-70. PubMed ID: 16170352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
    Liu J; Yuan Y; Huan J; Shen Z
    Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The breast cancer susceptibility gene, BRCA2: at the crossroads between DNA replication and recombination?
    Venkitaraman AR
    Philos Trans R Soc Lond B Biol Sci; 2000 Feb; 355(1394):191-8. PubMed ID: 10724455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.